Zeolitic imidazolate framework-8 as efficient pH-sensitive drug delivery vehicle
Chunyi Sun, Chao Qin, Xinlong Wang, Guang‐Sheng Yang, Kui‐Zhan Shao, Ya‐Qian Lan, Zhong‐Min Su, Peng Huang, Chungang Wang, En‐Bo Wang
Abstract
Chunyi Sun, Chao Qin, Xinlong Wang, Guang‐Sheng Yang, Kui‐Zhan Shao, Ya‐Qian Lan, Zhong‐Min Su, Peng Huang, Chungang Wang, En‐Bo Wang
Abstract
Zeolitic Imidazolate Framework-8 (ZIF-8), for the first time for ZIFs, exhibits a remarkable capacity for the anticancer drug 5-fluorouracil (5-FU), around 660 mg of 5-FU/g of ZIF-8, and presents a pH-triggered controlled drug release property. These prove ZIF-8 to be a valuable candidate for delivery of anticancer agents and reveal its potential applications in the treatment of cancer.
OpenAlex reports 715 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Zeolitic Imidazolate Framework-8 (ZIF-8), for the first time for ZIFs, exhibits a remarkable capacity for the anticancer drug 5-fluorouracil (5-FU), around 660 mg of 5-FU/g of ZIF-8, and presents a pH-triggered controlled drug release property. These prove ZIF-8 to be a valuable candidate for delivery of anticancer agents and reveal its potential applications in the treatment of cancer.
Key concepts: Zeolitic imidazolate framework, Imidazolate, Drug delivery, Drug, Anticancer drug, Chemistry, Nanotechnology, Combinatorial chemistry